EUVIMEDEUVIMED entdecken
Crossref

Plasma D-Dimer as a Disease Progression Marker in Operable Breast Cancer

Md Shahiduzzaman, Ahmed Sami Al Hasan, Rahad Bin Kashem, Muhammad Quamruzzaman, Israt Jahan, Tashreefa Amreen Haque

Journal of Surgical Sciences · 21.04.2026 · 27 (2) · 37-40

DOI: 10.3329/jss.v27i2.86390 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Sciences, online erschienen am 21.04.2026. Verfasst von Md Shahiduzzaman und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Identifying reliable prognostic markers is crucial for early intervention and improved survival in breast cancer. Plasma D-dimer, a fibrin degradation product, has been implicated in cancer progression and metastasis. This study was conducted to evaluate the significance of plasma Ddimer as a disease progression marker in Bangladeshi women with operable breast cancer, and its correlation with tumor size, histological grade, lymph node status, and hormone receptor profile.

Methods

An observational cross-sectional study was conducted at Dhaka Medical College Hospital between July and December 2018. Fifty women aged 20–60 years with operable breast cancer were enrolled using systematic random sampling. Clinical, radiological, and histopathological evaluations were performed. Plasma D-dimer levels were measured and analyzed against clinicopathological variables using SPSS v20.

Results

The mean age of patients was 46.2±14.2 years. The majority (42%) were aged 41–50 years. Left breast involvement predominated (58%), and 52% presented with diffuse whole-breast disease. Most tumors were ³T3 stage (76%). Elevated D-dimer levels correlated significantly with larger tumor size (mean 3.22 mg/ml for T4), higher histological grade (2.67 mg/ml for grade III), lymphovascular invasion (2.5 mg/ml vs. 0.5 mg/ml, p

Zitieren

APA

Shahiduzzaman, M., Hasan, A. S. A., Kashem, R. B., Quamruzzaman, M., Jahan, I., & Haque, T. A. (2026). Plasma D-Dimer as a Disease Progression Marker in Operable Breast Cancer. Journal of Surgical Sciences, 27(2), 37-40. https://doi.org/10.3329/jss.v27i2.86390

Vancouver

Shahiduzzaman M, Hasan ASA, Kashem RB, Quamruzzaman M, Jahan I, Haque TA. Plasma D-Dimer as a Disease Progression Marker in Operable Breast Cancer. Journal of Surgical Sciences. 2026;27(2):37-40. doi:10.3329/jss.v27i2.86390

BibTeX
@article{Shahiduzzaman2026,
  author = {Shahiduzzaman, Md and Hasan, Ahmed Sami Al and Kashem, Rahad Bin and Quamruzzaman, Muhammad and Jahan, Israt and Haque, Tashreefa Amreen},
  title = {Plasma D-Dimer as a Disease Progression Marker in Operable Breast Cancer},
  journal = {Journal of Surgical Sciences},
  year = {2026},
  volume = {27},
  number = {2},
  pages = {37--40},
  doi = {10.3329/jss.v27i2.86390}
}
Kostenlos starten →